Enanta Pharmaceuticals CEO Luly Jay R. buys $256,050 in common stock
In a recent transaction, Luly Jay R., the President and CEO of Enanta Pharmaceuticals Inc . (NASDAQ:ENTA), acquired 45,000 shares of the company's common stock. The purchase, made on February 12, 2025 ...
JMP Securities maintains Confluent stock with $40 target
JMP Securities analyst reiterated a Market Outperform rating with a $40.00 price target for Confluent Inc (NASDAQ:CFLT), representing potential upside for the $9.87 billion market cap company. The ...
The American Journal of Managed Care2d
Academic Cancer Centers See Longer Survival in CLL, MCL Than Community Centers
Patients treated in community settings were more likely to be older, less likely to be White, and had worse survival rates, ...
Study shows initial success but long-term challenges of 2019 Medicare opioid safety policy
A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that a 2019 Medicare opioid safety ...